About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lymphoma Clinical Trials in Boston | 559 Studies

Clinical Trials LymphomaBoston

Lymphoma Clinical Trials in Boston

Find 559 clinical trials for lymphoma near Boston, Massachusetts. Connect with research centers in your area.

All Lymphoma trials nationwide All trials in Boston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 521-540 of 559 trials

WithdrawnMulti-antigen CMV-Modified Vaccinia Ankara Vaccine in Reducing CMV Related Complications in Patients With Blood Cancer Undergoing Donor Stem Cell TransplantThis randomized phase II trial studies how well multi-antigen cytomegalovirus (CMV)-modified vaccinia Ankara vaccine works in reducing CMV related complications in patients with…NCT03438344·Duarte, California and 2 others CompletedA Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia and Non-Hodgkin LymphomaThis is a Phase 1, open-label, multicenter study evaluating the safety and PK profile of ABT-199 under a once daily dosing schedule.NCT01328626·Tucson, Arizona and 9 others

Lymphoma Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

Active not recruitingPirtobrutinib and Venetoclax in Waldenström MacroglobulinemiaThis study is being done to examine the safety and effectiveness of pirtobrutinib combined with venetoclax as a possible treatment for participants with Waldenström…NCT05734495·Boston, Massachusetts and 1 other

TerminatedSelumetinib in Treating Patients With Relapsed or Refractory Diffuse Large B-cell LymphomaThis phase II clinical trial is studying how well selumetinib works in treating patients with relapsed or refractory diffuse large B-cell lymphoma.NCT01278615·Chicago, Illinois and 15 others

TerminatedRituximab, Temozolomide, and Methylprednisolone in Treating Patients With Recurrent Primary CNS Non-Hodgkin's LymphomaRATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growth in different ways. Some block the ability of cancer cells to grow and spread.NCT00248534·San Francisco, California and 6 others

CompletedStudy of ONTAK® to Treat Cutaneous T-Cell Lymphoma (CTCL)The purpose of this research study is to evaluate how effective ONTAK is in the treatment of cutaneous T-cell Lymphoma (CTCL) and determine whether the presence of a type of…NCT00211198·Duarte, California and 8 others

TerminatedPh II CHOP+Velcade in Mediastinal LBCLThe main purpose of this study is to begin to collect information and try to learn whether or not VELCADE, when added to standard chemotherapy with CHOP/Rituxan, works in treating…NCT00361621·Boston, Massachusetts

CompletedStudy of COLAL-PRED to Treat Moderate to Severe Ulcerative ColitisThe purpose of this study is to determine whether COLAL-PRED is a safe and effective treatment for patients with moderate to severe ulcerative colitis.NCT00676832·Birmingham, Alabama and 88 others

CompletedA Safety Study of SGN-CD19A for Leukemia and LymphomaThis is a phase 1, open-label, dose-escalation, multicenter study to evaluate the safety and tolerability of SGN-CD19A in adult and pediatric patients with relapsed or refractory…NCT01786096·Birmingham, Alabama and 12 others

CompletedAzacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene RearrangementThis pilot phase II trial studies the side effects of azacitidine and combination chemotherapy in infants with acute lymphoblastic leukemia and KMT2A gene rearrangement.NCT02828358·Birmingham, Alabama and 169 others

TerminatedPhase 2 Study of AFM13 in Combination With AB-101 in Subjects With R/R HL and CD30+ PTCLAFM13-203 is a phase 2, open-label, multi-center, multi-cohort study with a safety run-in followed by expansion cohorts.NCT05883449·Birmingham, Alabama and 14 others

RecruitingA Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)The goal of this study is to compare how well sonrotoclax plus zanubrutinib works versus zanubrutinib plus placebo in treating adults with relapsed/refractory (R/R) mantle cell…NCT06742996·Birmingham, Alabama and 144 others

CompletedBortezomib and Lenalidomide in Treating Patients With Relapsed or Refractory Mantle Cell LymphomaThis phase II trial studies how well bortezomib and lenalidomide work in treating patients with mantle cell lymphoma that has come back after a period of improvement (refractory)…NCT00553644·Anaheim, California and 81 others

Active not recruitingCopanlisib Plus Venetoclax in R/R DLBCLThis research study is evaluating the combination of two drugs, copanlisib and venetoclax, as a possible treatment for trelapsed/refractory diffuse large B-cell lymphoma…NCT04572763·Duarte, California and 2 others

TerminatedSafety, Tolerability, Pharmacokinetics and Efficacy of AMG 397 in Subjects With Selected Relapsed or Refractory Hematological MalignanciesEvaluate the safety and tolerability of AMG 397. Estimate the maximum tolerated doses (MTDs) and/or biologically active doses.NCT03465540·Birmingham, Alabama and 20 others

WithdrawnAlemtuzumab Plus Fludarabine and Melphalan With or Without Cyclosporine, Mycophenolate Mofetil, and Low-Dose Total-Body Irradiation Therapy Followed by Donor Peripheral Stem Cell Transplant in Treating Patients With Hematologic CancerRATIONALE: Giving low doses of chemotherapy, monoclonal antibodies, and radiation therapy before a donor peripheral blood stem cell transplant helps stop the growth of cancer…NCT00085449·La Jolla, California and 23 others

CompletedOral Clofarabine for Relapsed/Refractory Non-Hodgkin LymphomaOral clofarabine is related to two intravenous chemotherapy drugs used for this disease and works in two different ways.NCT00644189·Boston, Massachusetts and 1 other

CompletedUse Feasibility of the iThermonitor in Pediatrics Patients on Myelosuppresive TherapiesThis is a pilot study to evaluate the use feasibility of the iThermonitor, a continuous temperature monitoring device, as a clinical support and patient self-management tool in…NCT02410252·Boston, Massachusetts

CompletedALRN-6924 in Patients With Advanced Solid Tumors or LymphomasThis study evaluates the anti-tumor effects of ALRN-6924 in patients with advanced solid tumors or lymphomas with WT TP53.NCT02264613·Birmingham, Alabama and 12 others

CompletedEpoetin Alfa in Treating Anemia in Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma and Anemia Caused By ChemotherapyRATIONALE: Drugs such as epoetin alfa may relieve anemia caused by chemotherapy. The best time for giving epoetin alfa during chemotherapy is not yet known.NCT00003341·Berkeley, California and 17 others

PreviousPage 27 of 28Next

Other Conditions in Boston

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia